FilingSEC EDGAR424B5
Kazia Therapeutics Announces Approximately $37 Million ADS and Warrant Offering
· SEC accepted
Stageclinical
Filing content
Kazia Therapeutics is conducting an offering of ADSs and warrants for approximately $37 million in net proceeds, intended for the clinical development of paxalisib.
AI summary of the filing. Please also check the source.Related companies
Analyzed by WAPE AI.
Preparing English content…
Comments —
Loading comments…